<DOC>
	<DOCNO>NCT01693146</DOCNO>
	<brief_summary>Evaluation Safety Efficacy Short time TNI Treatment Patients COPD hypercapnia . Acute test oxygen demand use TNI vs. standard oxygen application stable COPD patient hypercapnia .</brief_summary>
	<brief_title>STIT-2 : Evaluation Safety Efficacy Short-time TNI® Treatment Patients With COPD Hypercapnia</brief_title>
	<detailed_description>TNI , nasal insufflation high flow warm , humidify air , extremely comfortable uncomplicated alternative numerous approach non-invasive ventilation ( NIV ) . Up , NIV therapy could apply mask associated complication patient could tolerate high airflow deliver thin nasal cannula without humidification warming , thus cause concomitant negative effect . The new therapy TNI show high rate acceptance child , . At present , two different type device available nasal insufflation clinic : TNI 20 , air humidifier clinical compress air , TNI20 oxy , air humidifier clinical compress air , combine oxygen . TNI 20 oxy The system , unique throughout world , optimize application flow 20L/min fulfils minimum requirement `` American Society Testing Materials '' high flow air humidifier non-invasive application 10 mg H2O/L ( equivalent 60 % rel . humidity ambient temperature 22°C ) air humidity . The warm air flow 5-15°C adjusted relative ambient temperature . Condensation prevent nasal applicator heat tube far nostrils . The device automatically control humidity temperature depend prevail ambient condition . The TNI®20s attach hospital infrastructure mean standard pressure regulator . In another ongoing study ( STIT-1 ) TNI 20 oxy evaluate safety COPD patient without hypercapnia . In first interim analysis include 14 patient high flow oxygen delivery safe .</detailed_description>
	<mesh_term>Hypercapnia</mesh_term>
	<criteria>COPD patient indication longterm oxygen therapy ( LTOT ) Presence hypercapnia rest without oxygen supplementation ( PaCO2 &gt; 45 mmHg ) Age 30 85 year Functional GOLD class : COPD GOLD IV define follow : FEV1/FVC &lt; 70 % Postbronchodilator FEV1 &lt; 30 % FEV1 &lt; 50 % PaO2 &lt; 60 mmHg and/or PaCO2 &gt; 50 mmHg Clinical instability patient No lung function test possible Exacerbation within last 14 day prior inclusion study Serious concomitant disease may jeopardize inclusion patient study investigator 's point view Severe anaemia , define haemoglobin &lt; 8.5 G/L Participation patient ongoing study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Oxygen</keyword>
	<keyword>High Flow</keyword>
	<keyword>COPD</keyword>
	<keyword>Hypercapnia</keyword>
</DOC>